DHL
Term · Oncology and biomedicine · MLC-T-ONC-002404
A rare, aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma caused by changes in the DNA that affect a gene called the MYC gene and either the BCL2 gene or the BCL6 gene. DHL may be hard to treat and has a poor prognosis. It is a type of diffuse large B-cell lymphoma. Also called double-hit lymphoma.
| Identifier | MLC-T-ONC-002404 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | double-hit lymphoma |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002404",
"term": "DHL",
"field": "Oncology and biomedicine",
"definition": "A rare, aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma caused by changes in the DNA that affect a gene called the MYC gene and either the BCL2 gene or the BCL6 gene. DHL may be hard to treat and has a poor prognosis. It is a type of diffuse large B-cell lymphoma. Also called double-hit lymphoma.",
"expansions": [
"double-hit lymphoma"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dhl/"
}
Record 5,919 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.